Assessment of Comfort Level Following an Intravitreal Injection by 30 or 32 Gauge Needles

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Pain
Interventions
DEVICE

Eye injection by 30 or 32 gauge needle

Consented patients receiving monthly bi-lateral injections of the same dose of ranibizumab will have one eye injected with a 30 gauge needle and the other eye injected with a 32 gauge needle. Bi-lateral injections may be performed on the same day or with one week of each other, depending on the subject preference and their normal injection regimen. On the first visit following enrollment in the study, the eye to receive the injection from the 30 or 32 gauge needle will be determined randomly. The other eye will be injected with the other needle size. When the patient returns for their next set of bi-lateral injections, the eyes receiving the 30 and 32 gauge needle injection will switch.

Trial Locations (1)

33907

RECRUITING

Retina Health Center, Fort Myers

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

California Retina Consultants

OTHER

collaborator

Genentech, Inc.

INDUSTRY

lead

Retina Health Center

INDUSTRY